Allogene Therapeutics to Participate in Jefferies Global Healthcare Conference

Reuters
2025.11.10 13:30
portai
I'm PortAI, I can summarize articles.

Allogene Therapeutics Inc. will participate in the Jefferies Global Healthcare Conference in London on November 18. The company focuses on developing allogeneic CAR T products for cancer and autoimmune diseases. This announcement is for informational purposes only and should not be considered financial or legal advice.

Allogene Therapeutics Inc., a clinical-stage biotechnology company developing allogeneic CAR T products for cancer and autoimmune disease, will participate in the Jefferies Global Healthcare Conference in London on Tuesday, November 18. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allogene Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9572233-en) on November 10, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer